These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 17804904

  • 21. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
    Hood SA, O'Brien M, Higgins R.
    Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis].
    Ficheux M, Cuny P, Lecouf A, Ryckelynck JP, Hurault de Ligny B, Lobbedez T.
    Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234
    [Abstract] [Full Text] [Related]

  • 23. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB, Boyd AV, McQuade CR, Harford A, Norenberg JP, Zager PG.
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A trial of two iron-dextran infusion regimens in chronic hemodialysis patients.
    Agarwal R, Davis JL, Hamburger RJ.
    Clin Nephrol; 2000 Aug; 54(2):105-11. PubMed ID: 10968685
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB, Pljesa SI, Rasić ZR, Stanković SD, Ilić MN.
    Med Pregl; 2007 Aug; 60 Suppl 2():43-7. PubMed ID: 18928156
    [Abstract] [Full Text] [Related]

  • 32. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.
    Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    Sav T, Tokgoz B, Sipahioglu MH, Deveci M, Sari I, Oymak O, Utas C.
    Ren Fail; 2007 Jun; 29(4):423-6. PubMed ID: 17497463
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.